We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current M1RN34 market cap is 12.52B. The company's latest EPS is USD -12.3635 and P/E is -10.32.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 5.08B | 1.86B | 344M | 1.83B | 2.81B |
Operating Income | 1.58B | -366M | -1.87B | -2.01B | 6M |
Net Income | 1.47B | 79M | -1.38B | -3.63B | 217M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 60.21M | 803.4M | 18.47B | 19.26B | 6.85B |
Operating Income | -545.72M | -763.14M | 13.3B | 9.42B | -4.24B |
Net Income | -514.02M | -747.1M | 12.2B | 8.36B | -4.71B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 25.86B | 24.13B | 21.88B | 19.45B | 18.43B |
Total Liabilities | 6.74B | 5.26B | 4.94B | 6B | 4.57B |
Total Equity | 19.12B | 18.86B | 16.95B | 13.46B | 13.85B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.59B | 7.34B | 24.67B | 25.86B | 18.43B |
Total Liabilities | 414.61M | 4.78B | 10.52B | 6.74B | 4.57B |
Total Equity | 1.17B | 2.56B | 14.15B | 19.12B | 13.85B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 4.98B | -1.23B | -2.14B | -3.74B | -3.12B |
Investing | -5.18B | 2.01B | 3.96B | 4.74B | 4.21B |
Financing | -3.45B | -542M | -1.21B | -1.27B | -1.38B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -458.97M | 2.03B | 13.62B | 4.98B | -3.12B |
Investing | -14.95M | -1.67B | -8.52B | -5.18B | 4.21B |
Financing | 51.12M | 2.03B | -873M | -3.45B | -1.38B |
Market Cap | 12.52B |
Price to Earnings Ratio | -10.32 |
Price to Sales Ratio | 7.1 |
Price to Cash Ratio | 16.74 |
Price to Book Ratio | 3.51 |
Dividend Yield | - |
Shares Outstanding | 381.28M |
Average Volume (1 week) | 5.05k |
Average Volume (1 Month) | 14.8k |
52 Week Change | 3.66% |
52 Week High | 35.10 |
52 Week Low | 16.70 |
Spread (Intraday) | 0.07 (0.21%) |
Company Name | Moderna Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.modernatx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions